Infinity Pharmaceuticals Inc.

NASDAQ:INFI   10:03:44 AM EDT
2.66
0.00 (0.00%)
Other Pre-Announcement

Infinity Pharmaceuticals Expects Net Loss For 2021 To Range From $40 Mln To $50 Mln

Published: 03/16/2021 20:17 GMT
Infinity Pharmaceuticals Inc. (INFI) - Infinity Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Eganelisib Development.
Infinity Pharmaceuticals - Expects Net Loss for 2021 to Range From $40 Million to $50 Million.
Infinity Pharmaceuticals - Expects to End 2021 With Cash, Equivalents & Available for Sale Securities Balance Ranging From $70 Million to $80 Million.